Back

Temporal trends in initiation of oral anticoagulants and stroke-free survival among elderly and very elderly patients with new onset atrial fibrillation - a 20-year perspective.

1 September 2024 (11:21 - 11:33)
Organised by: Logo
Congress Presentation Part of: Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians Oral Anticoagulation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mariam Elmegaard

Gentofte University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
How much does elective cardioversion increase the risk of ischaemic stroke compared to the baseline risk in atrial fibrillation? A nationwide study.
Mrs S. Itainen-Stromberg (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Stratification of residual thromboembolic risk among anticoagulated atrial fibrillation patients: a hierarchical cluster analysis from a global, real-world population
Doctor H. Ishiguchi (Ube, JP)
Abstract Slides Video
Presentation thumbnail
Cluster-specific risk factors for suboptimal thromboprophylaxis in contemporary European cohort of patients with atrial fibrillation: the EHRA-PATHS Project
Doctor M. Mihajlovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Is atrial fibrillation associated with increased risk of stroke after transient ischaemic attack?
Miss K. Al-Chaer (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:21 CET
You may be interested in
thumbnail
Congress Presentation
Care and outcomes of atrial fibrillation in potentially vulnerable populations: A 20-year perspective using real-world data
thumbnail
Congress Session
Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians
thumbnail
Congress Presentation
Implementation of new antithrombotic treatment strategies and outcome improvements in patients with myocardial infarction and atrial fibrillation over 20 years: a nationwide cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources